Current diagnosis and management of infectious mononucleosis

Current Opinion in Hematology

Volumn 19, Issue 1, 2012, Pages 14-20

  Vouloumanou, Evridiki K ^a   Rafailidis, Petros I ^a,b   Falagas, Matthew E ^a,b,c  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b HENRY DUNANT HOSPITAL   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acyclovir; Diagnosis; Epstein Barr virus; Serology; Valacyclovir

Indexed keywords

ACICLOVIR; AZACITIDINE; C REACTIVE PROTEIN; CIDOFOVIR; CORTICOSTEROID; FAMCICLOVIR; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOSUPPRESSIVE AGENT; URACIL DERIVATIVE; VALACICLOVIR; VIDARABINE; ANTIVIRUS AGENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

DRUG FATALITY; ENZYME IMMUNOASSAY; EPSTEIN BARR VIRUS; HEMATOLOGIC DISEASE; HEPATITIS; HUMAN; IMMUNOFLUORESCENCE TEST; INFECTIOUS MONONUCLEOSIS; LYMPHOCYTE COUNT; MEDLINE; MONOCYTE; NAUSEA; NEUROLOGIC DISEASE; NEUTROPHIL COUNT; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY ANALYSIS; SERODIAGNOSIS; SPLEEN RUPTURE; VIRUS LOAD; IMMUNOLOGY; METHODOLOGY; POLYMERASE CHAIN REACTION;

ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFECTIOUS MONONUCLEOSIS; POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 84856404531     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32834daa08     Document Type: Review

References (27)

1. Tosato G, Straus S, Henle W, et al. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). J Immunol 1985; 134:3082-3088.
2. Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl J Med 2010; 362:1993-2000.
3. Maakaroun NR, Moanna A, Jacob JT, et al. Viral infections associated with haemophagocytic syndrome. Rev Med Virol 2010; 20:93-105.
4. Darteyre S, Ludwig C, Jeziorski E, et al. Hemophagocytic lymphohistiocytosis and Epstein-Barr virus infection in children. Med Mal Infect 2010; 40:18-26.
5. Kagoya Y, Hangaishi A, Takahashi T, et al. High-dose dexamethasone therapy for severe thrombocytopenia and neutropenia induced by EBV infectious mononucleosis. Int J Hematol 2010; 91:326-327.
6. Usov IN. 50th anniversary of the Byelorussian Pediatric Society. Pediatriia 1983; 72-74.
7. Rafailidis PI, Mavros MN, Kapaskelis A, et al. Antiviral treatment for severe EBV infections in apparently immunocompetent patients. J Clin Virol 2010; 49:151-157.
8. Berth M, Bosmans E. Comparison of three automated immunoassay methods for the determination of Epstein-Barr virus-specific immunoglobulin M. Clin Vaccine Immunol 2010; 17:559-563.
9. Berth M, Vanheule G, Depuydt C, et al. Serum Epstein-Barr virus (EBV) viral load can be a complementary sensitive test in primary Epstein-Barr virus infection. J Clin Virol 2011; 50:184-185.
10. Devanthery O, Meylan P. Comparison of a multiplexed bead-based assay with an immunofluorescence and an enzyme-immuno assay for the assessment of Epstein-Barr virus serologic status. Clin Microbiol Infect 2010; 16:1776-1782.
11. Dohno S, Maeda A, Ishiura Y, et al. Diagnosis of infectious mononucleosis caused by Epstein-Barr virus in infants. Pediatr Int 2010; 52:536-540.
12. Gartner B, Preiksaitis JK. EBV viral load detection in clinical virology. J Clin Virol 2010; 48:82-90.
13. Janols H, Bredberg A, Thuvesson I, et al. Lymphocyte and monocyte flow cytometry immunophenotyping as a diagnostic tool in uncharacteristic inflammatory disorders. BMC Infect Dis 2010; 10:205.
14. Lay ML, Lucas RM, Ratnamohan M, et al. Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye. Virol J 2010; 7:252.
15. Lennon P, JP O'Neill, Fenton JE, et al. Challenging the use of the lymphocyte to white cell count ratio in the diagnosis of infectious mononucleosis by analysis of a large cohort of Monospot test results. Clin Otolaryngol 2010; 35:397-401.
16. Macsween KF, Higgins CD, McAulay KA, et al. Infectious mononucleosis in university students in the United Kingdom: evaluation of the clinical features and consequences of the disease. Clin Infect Dis 2010; 50:699-706.
17. De Paoli P. Epstein-Barr virus: novel patented therapeutics. Expert Opin Ther Pat 2010; 20:807-818.
18. Vezina HE, Balfour HH Jr, Weller DR, et al. Valacyclovir pharmacokinetics and exploratory pharmacodynamics in young adults with Epstein-Barr virus infectious mononucleosis. J Clin Pharmacol 2010; 50:734-742.
19. Huang Y, Katz BZ, Mears C, et al. Postinfectious fatigue in adolescents and physical activity. Arch Pediatr Adolesc Med 2010; 164:803-809.
20. Candy B, Hotopf M. Steroids for symptom control in infectious mononucleosis. Cochrane Database Syst Rev 2006; 3:CD004402.
21. Thompson SK, Doerr TD, Hengerer AS. Infectious mononucleosis and corticosteroids: management practices and outcomes. Arch Otolaryngol Head Neck Surg 2005; 131:900-904.
22. Falagas ME, Koletsi PK, Vouloumanou EK, et al. Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 2010; 65:1330-1346.
23. Falagas ME, Vouloumanou EK, Baskouta E, et al. Treatment options for 2009 H1N1 influenza: evaluation of the published evidence. Int J Antimicrob Agents 2010; 35:421-430.
24. Rafailidis PI, Kapaskelis A, Falagas ME. Cytomegalovirus meningitis in an immunocompetent patient. Med Sci Monit 2007; 13:CS107-CS109.
25. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, et al. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 2008; 5:47.
26. Torre D, Tambini R. Acyclovir for treatment of infectious mononucleosis: a meta-analysis. Scand J Infect Dis 1999; 31:543-547.
27. Allen UD. Epstein-Barr virus vaccination of transplant candidates: light at the end of the tunnel? Transplantation 2009; 88:976-977.